# AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology
Canonical URL: https://biopharmsignal.com/news/AMN/amn-healthcare-acquires-jaide-health-to-expand-language-access-across-the-patien-ca9f1e96
Ticker: AMN
Company: AMN Healthcare
Source: AMN Healthcare
Published: 2026-06-09 13:00 EST
## Summary

Acquisition strengthens end-to-end support for Limited English Proficiency (LEP) patients by pairing high-quality AI assistance with AMN’s trusted human...

## Article Body
AMN Healthcare’s Language Services today announced it has acquired Jaide Health, a real-time, AI-enabled medical interpretation and translation solution designed to help patients and care teams communicate more quickly and easily throughout the administrative aspects of the healthcare experience. The acquisition expands AMN Language Services’ ability to support LEP patients not only during clinical encounters requiring human interaction, but also in key moments before and after care—while reinforcing the essential role of medically qualified human interpreters for clinical, complex, and sensitive conversations.

Jaide Health provides high-quality, AI-assisted language support for common, everyday verbal exchanges and written translations, such as sharing intake and discharge information, helping close gaps outside the physician or acute-care encounter where patients and staff often experience delays or limited language access. When conversations become clinical or complex, human interpreters remain central to ensuring accuracy, empathy, and patient safety.

“This is an important strategic move in AMN’s ongoing mission to improve access to care for all,” said Cary Grace, President and CEO of AMN Healthcare. “By expanding language support across more moments in the healthcare journey, we can help health systems deliver a more seamless experience for patients and care teams while continuing to rely on the critical expertise of our qualified interpreters when it matters most.”

The Jaide Health solution is live today with clients across multiple healthcare environments, demonstrating value in real-world workflows and patient communications.

“We believe we’ve built one of the strongest solutions in the market, and joining AMN Language Services lets us reach more patients through AMN’s scale and clinical-quality standards,” said Joe Corkery, MD, CEO and co-founder of Jaide Health. “AMN was our first choice because of our shared commitment to quality. Together, we can pair smart AI assistance with the high standards of AMN’s human interpreting to provide LEP patients with a voice outside of clinical encounters, which we know leads to better outcomes and experiences.”

As part of the acquisition, the Jaide Health team will join AMN Healthcare. Financial terms of the transaction were not disclosed.

About AMN Healthcare

AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2025 our healthcare professionals reached more than 13 million patients at more than 2,300 healthcare systems, including 93 percent of the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.
## Recent Company News
- 2026-06-09 13:00 EST — [AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology](https://biopharmsignal.com/news/AMN/amn-healthcare-acquires-jaide-health-to-expand-language-access-across-the-patien-ca9f1e96) — Source: AMN Healthcare
- 2026-05-13 14:02 EST — [Eric Palmer Joins AMN Healthcare Board of Directors](https://biopharmsignal.com/news/AMN/eric-palmer-joins-amn-healthcare-board-of-directors-b98bda3c) — Source: AMN Healthcare
- 2026-05-07 20:15 EST — [AMN Healthcare Announces First Quarter 2026 Results](https://biopharmsignal.com/news/AMN/amn-healthcare-announces-first-quarter-2026-results-69e52158) — Source: AMN Healthcare
- 2026-04-09 11:30 EST — [AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026](https://biopharmsignal.com/news/AMN/amn-healthcare-to-hold-first-quarter-2026-earnings-conference-call-on-thursday-m-09f1e3de) — Source: AMN Healthcare
- 2026-02-26 15:00 EST — [AMN Healthcare Survey Reveals Sharp Divide Between Leaders’ Organizational Confidence and Industry Outlook for 2026](https://biopharmsignal.com/news/AMN/amn-healthcare-survey-reveals-sharp-divide-between-leaders-organizational-confid-69477fad) — Source: AMN Healthcare
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)